SCHEMBL3606588

SCHEMBL3606588

c1cc(-c2cc3ccc4cnccc4c3[nH]2)ccn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CLK1 P49759 1/20 0.44
▸ CDK4 P11802 1/20 0.43
▸ CCND1 P24385 1/20 0.43
▸ CDC7 O00311 3/20 0.40
▸ GCGR P47871 2/20 0.40
▸ MAPK14 Q16539 2/20 0.40
▸ PIM1 P11309 2/20 0.39
▸ PKN2 Q16513 1/20 0.39
▸ HASPIN Q8TF76 1/20 0.39
▸ PRKCD Q05655 2/20 0.38
▸ GSK3B P49841 2/20 0.38
▸ DYRK1A Q13627 2/20 0.38
▸ AURKA O14965 1/20 0.38
▸ DAPK3 O43293 1/20 0.38
▸ JAK2 O60674 1/20 0.38
▸ ROCK2 O75116 1/20 0.38
▸ CHEK2 O96017 1/20 0.38
▸ CDK1 P06493 1/20 0.38
▸ FGFR1 P11362 1/20 0.38
▸ PRKACA P17612 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3603159 0.90 CDK4 (0.48) CDK4CCND1CDC7GCGRMAPK14
SCHEMBL3599649 0.88 CDK1 (0.44) CLK1CDK4CCND1CDC7GCGR
SCHEMBL3591016 0.79 MAPK10 (0.50) FGFR1KDRRPS6KA3IMPDH2
SCHEMBL3599017 0.78 RPS6KA3 (0.44) AURKAJAK2CHEK2FGFR1CSNK1D
SCHEMBL24746791 0.77 CDC7 (0.45) CLK1CDC7PKN2PRKCDGSK3B
SCHEMBL30064139 0.77 CDC7 (0.45) CLK1CDC7PKN2PRKCDGSK3B
SCHEMBL10142469 0.76 CDK4 (0.45) CLK1CDK4CCND1CDC7PIM1
SCHEMBL10174660 0.72 ERN1 (0.51) CLK1CDK4CCND1CDC7PIM1
SCHEMBL27075650 0.72 CYP19A1 (0.53) CLK1CDC7PIM1HASPINGSK3B
SCHEMBL3598248 0.71 HPGD (0.62) CDK4CCND1CDC7PIM1HASPIN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2118102-B1 TRICYCLIC INDOLES AND (4,5-DIHYDRO) INDOLES NERVIANO MEDICAL SCIENCES SRL (IT) 2013-06-12 — — EP disclosed
US-8207180-B2 Tricyclic indoles and (4,5-dihydro) indoles NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-06-26 — — US disclosed
US-20100075998-A1 TRICYCLIC INDOLES AND (4,5-DIHYDRO) INDOLES NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2010-03-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100075998-A1 TRICYCLIC INDOLES AND (4,5-DIHYDRO) INDOLES CDC7, CDK7, CDK17 CLK1 228/4885CDK4 64/4885CCND1 113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback